Jens Grueger

Jens Grueger, PhD

Jens Grueger, PhD is a Director and Partner at Boston Consulting Group (BCG) in Zurich, Switzerland, where he is the senior expert for pricing and market access in the life sciences.12 He is also an Affiliate Professor of Health Economics at the Comparative Health Outcomes, Economics and Policy (CHOICE) Institute at the University of Washington in Seattle.1

Grueger has been a member of the Board of Directors at the Drug Information Association (DIA) since 2023.3456 He previously served as the 2020-2021 President of ISPOR, the largest professional society for health economics and outcomes research.1

Before joining BCG in 2019, Grueger had a 25-year career in the pharmaceutical industry, leading global pricing, market access, and health policy functions at Novartis, Pfizer, and Roche.12 At Roche, he drove holistic access strategies to ensure rapid, broad, and sustainable patient access to the company's innovative offerings.2

Grueger was trained in mathematics and medicine, receiving a master's degree in medical statistics (1984) and a PhD in theoretical statistics (1986) from the Technical University of Dortmund in Germany.2 He started his professional career as a health systems researcher, consulting with governments and payers from 1986 to 1994.2

As a member of the DIA Board of Directors, Grueger helps provide strategic clarity, direction, and policy objectives to offer all stakeholders opportunities to co-create, problem-solve, and illuminate cohesive pathways to the future of global and regional life sciences developments.4